Binnacle Investments Inc Ascendis Pharma A/S Transaction History
Binnacle Investments Inc
- $137 Billion
- Q1 2025
A detailed history of Binnacle Investments Inc transactions in Ascendis Pharma A/S stock. As of the latest transaction made, Binnacle Investments Inc holds 3 shares of ASND stock, worth $512. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3Holding current value
$512% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ASND
# of Institutions
250Shares Held
60.3MCall Options Held
80.3KPut Options Held
216K-
Ra Capital Management, L.P. Boston, MA10.1MShares$1.73 Billion22.55% of portfolio
-
Westfield Capital Management CO LP Boston, MA5.48MShares$936 Million4.42% of portfolio
-
Avoro Capital Advisors LLC New York, NY5.1MShares$871 Million10.24% of portfolio
-
Janus Henderson Group PLC London, X04.38MShares$748 Million0.32% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI4.26MShares$727 Million1.14% of portfolio
About Ascendis Pharma A/S
- Ticker ASND
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,810,200
- Market Cap $9.53B
- Description
- Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...